Definitive Healthcare Announces Timing of Its Third Quarter 2022 Financial Results Conference Call and Webcast
Definitive Healthcare Corp. (Nasdaq: DH) will release its third-quarter financial results for the period ending September 30, 2022, on November 3, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Definitive Healthcare Corp. (Nasdaq: DH) will release its third-quarter financial results for the period ending September 30, 2022, on November 3, 2022, after market close. A conference call and webcast to discuss these results will take place at 5:00 PM ET. Investors can access a live audio webcast on the company’s Investor Relations website. A replay will be available until November 17, 2022. Definitive Healthcare specializes in healthcare commercial intelligence, helping clients navigate market opportunities through its SaaS platform.
Positive
- Scheduled release of third-quarter financial results, indicating transparency and engagement with investors.
Negative
- None.
Details
News Market Reaction – DH
The recorded move for DH in the trading session of this news was +2.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FRAMINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its third quarter ended September 30, 2022 financial results will be released on Thursday, November 3, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
A live audio webcast of the event will be available on the Definitive Healthcare’s Investor Relations website at https://ir.definitivehc.com/.
A live dial-in will be available at (844) 826-3033 (domestic) or (412) 317-5185 (international). The conference ID number is 10170962. Shortly after the conclusion of the call, a replay of this conference call will be available through November 17, 2022 at (844) 512-2921 (domestic) or (412) 317-6671 (international). The replay passcode is 10170962.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data, analytics and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.
Media Contact:
Danielle Johns
djohns@definitivehc.com
Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com
646-277-1251
Source: Definitive Healthcare Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.